MetaCap

Tyra Biosciences Statistics

NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

20.12+0.39 (+1.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Tyra Biosciences by the numbers

Tyra Biosciences has a market capitalization of $1.39 billion based on 69.08M shares outstanding. With trailing EPS of $-2.63, Tyra Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.4% below its 50-day average and 30.9% below its 200-day average.

Average daily trading volume is 852.56K shares, or about $17.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TYRA valuation vs. peer median

TYRA compared with the median of 8 peer companies
MetricTYRAPeer medianDifference
Market cap$1.39B$1.36B+2%
Avg. volume852.56K948.24K-10%

Peer median across 8 companies: QURE, URGN, RAPP, PAHC, NBTX, NUVB, ANAB, NRIX.

Valuation

Price and trading

Previous close
19.73
Open
19.62
Day range
19.62 – 20.44
52-week range
18.25 – 40.65
52-week change
-4.73%
Beta
—
Volume
467.58K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
1.39B
Forward Pe
-6.83
Eps
-2.63
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
40.65
Week52 Low
18.25
Avg Volume
852.56K
Shares Outstanding
69.08M
Ma50
21.27
Ma200
29.14
Earnings Date
Nov 10, 2026
Pct From52w High
-50.50%
Pct From52w Low
10.25%

Related